Cargando…

Association Between a Variable Number Tandem Repeat Polymorphism Within the DAT1 Gene and the Mesolimbic Pathway in Parkinson's Disease

The loss of ventral striatal dopaminergic neurons in Parkinson's disease (PD) predicts an impact on the reward system. The ventrostriatal system is involved in motivational processing and its dysfunction may be related to non-motor symptoms such as depression and apathy. We previously documente...

Descripción completa

Detalles Bibliográficos
Autores principales: du Plessis, Stefan, Bekker, Minke, Buckle, Chanelle, Vink, Matthijs, Seedat, Soraya, Bardien, Soraya, Carr, Jonathan, Abrahams, Shameemah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493621/
https://www.ncbi.nlm.nih.gov/pubmed/32982958
http://dx.doi.org/10.3389/fneur.2020.00982
_version_ 1783582595720675328
author du Plessis, Stefan
Bekker, Minke
Buckle, Chanelle
Vink, Matthijs
Seedat, Soraya
Bardien, Soraya
Carr, Jonathan
Abrahams, Shameemah
author_facet du Plessis, Stefan
Bekker, Minke
Buckle, Chanelle
Vink, Matthijs
Seedat, Soraya
Bardien, Soraya
Carr, Jonathan
Abrahams, Shameemah
author_sort du Plessis, Stefan
collection PubMed
description The loss of ventral striatal dopaminergic neurons in Parkinson's disease (PD) predicts an impact on the reward system. The ventrostriatal system is involved in motivational processing and its dysfunction may be related to non-motor symptoms such as depression and apathy. We previously documented that patients with PD had blunted Blood Oxygen Level Dependent functional magnetic resonance imaging (BOLD fMRI) reward task related activity during both reward anticipation (i.e., in the ventral striatum) and reward outcome (i.e., in the orbitofrontal cortex). Evidence for the modulation of brain function by dopaminergic genes in PD is limited. Genes implicated in dopamine transmission, such as the dopamine transporter gene (DAT1) may influence the clinical heterogeneity seen in PD, including reward processing. This study therefore sought to determine whether genetic differences in the DAT gene are associated with brain activity associated with response to reward in PD patients and controls. A sample of PD cases on treatment (n = 15) and non-PD controls (n = 30) from an ethnic group unique to South Africa were genotyped. We found a three-way interaction between GENOTYPE × BOLD fMRI REWARD × DIAGNOSIS [F((1, 40)) = 4.666, p = 0.037, partial η(2) = 0.104]. PD patients with the DAT1 homozygous 10/10 repeat genotype showed a relative decrease in orbitofrontal cortex reward outcome related activity compared to the patient group who did not have this repeat. PD patients with other genotypes showed an expected increase in orbitofrontal cortex reward outcome related activity compared to controls. Given the small sample size of the PD group with the 10/10 repeat, these results should be considered preliminary. Nevertheless, these preliminary findings highlight the potential modulation of dopamine transporter polymorphisms on orbitofrontal reward system activity in PD and highlight the need for further studies.
format Online
Article
Text
id pubmed-7493621
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-74936212020-09-24 Association Between a Variable Number Tandem Repeat Polymorphism Within the DAT1 Gene and the Mesolimbic Pathway in Parkinson's Disease du Plessis, Stefan Bekker, Minke Buckle, Chanelle Vink, Matthijs Seedat, Soraya Bardien, Soraya Carr, Jonathan Abrahams, Shameemah Front Neurol Neurology The loss of ventral striatal dopaminergic neurons in Parkinson's disease (PD) predicts an impact on the reward system. The ventrostriatal system is involved in motivational processing and its dysfunction may be related to non-motor symptoms such as depression and apathy. We previously documented that patients with PD had blunted Blood Oxygen Level Dependent functional magnetic resonance imaging (BOLD fMRI) reward task related activity during both reward anticipation (i.e., in the ventral striatum) and reward outcome (i.e., in the orbitofrontal cortex). Evidence for the modulation of brain function by dopaminergic genes in PD is limited. Genes implicated in dopamine transmission, such as the dopamine transporter gene (DAT1) may influence the clinical heterogeneity seen in PD, including reward processing. This study therefore sought to determine whether genetic differences in the DAT gene are associated with brain activity associated with response to reward in PD patients and controls. A sample of PD cases on treatment (n = 15) and non-PD controls (n = 30) from an ethnic group unique to South Africa were genotyped. We found a three-way interaction between GENOTYPE × BOLD fMRI REWARD × DIAGNOSIS [F((1, 40)) = 4.666, p = 0.037, partial η(2) = 0.104]. PD patients with the DAT1 homozygous 10/10 repeat genotype showed a relative decrease in orbitofrontal cortex reward outcome related activity compared to the patient group who did not have this repeat. PD patients with other genotypes showed an expected increase in orbitofrontal cortex reward outcome related activity compared to controls. Given the small sample size of the PD group with the 10/10 repeat, these results should be considered preliminary. Nevertheless, these preliminary findings highlight the potential modulation of dopamine transporter polymorphisms on orbitofrontal reward system activity in PD and highlight the need for further studies. Frontiers Media S.A. 2020-09-02 /pmc/articles/PMC7493621/ /pubmed/32982958 http://dx.doi.org/10.3389/fneur.2020.00982 Text en Copyright © 2020 du Plessis, Bekker, Buckle, Vink, Seedat, Bardien, Carr and Abrahams. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
du Plessis, Stefan
Bekker, Minke
Buckle, Chanelle
Vink, Matthijs
Seedat, Soraya
Bardien, Soraya
Carr, Jonathan
Abrahams, Shameemah
Association Between a Variable Number Tandem Repeat Polymorphism Within the DAT1 Gene and the Mesolimbic Pathway in Parkinson's Disease
title Association Between a Variable Number Tandem Repeat Polymorphism Within the DAT1 Gene and the Mesolimbic Pathway in Parkinson's Disease
title_full Association Between a Variable Number Tandem Repeat Polymorphism Within the DAT1 Gene and the Mesolimbic Pathway in Parkinson's Disease
title_fullStr Association Between a Variable Number Tandem Repeat Polymorphism Within the DAT1 Gene and the Mesolimbic Pathway in Parkinson's Disease
title_full_unstemmed Association Between a Variable Number Tandem Repeat Polymorphism Within the DAT1 Gene and the Mesolimbic Pathway in Parkinson's Disease
title_short Association Between a Variable Number Tandem Repeat Polymorphism Within the DAT1 Gene and the Mesolimbic Pathway in Parkinson's Disease
title_sort association between a variable number tandem repeat polymorphism within the dat1 gene and the mesolimbic pathway in parkinson's disease
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493621/
https://www.ncbi.nlm.nih.gov/pubmed/32982958
http://dx.doi.org/10.3389/fneur.2020.00982
work_keys_str_mv AT duplessisstefan associationbetweenavariablenumbertandemrepeatpolymorphismwithinthedat1geneandthemesolimbicpathwayinparkinsonsdisease
AT bekkerminke associationbetweenavariablenumbertandemrepeatpolymorphismwithinthedat1geneandthemesolimbicpathwayinparkinsonsdisease
AT bucklechanelle associationbetweenavariablenumbertandemrepeatpolymorphismwithinthedat1geneandthemesolimbicpathwayinparkinsonsdisease
AT vinkmatthijs associationbetweenavariablenumbertandemrepeatpolymorphismwithinthedat1geneandthemesolimbicpathwayinparkinsonsdisease
AT seedatsoraya associationbetweenavariablenumbertandemrepeatpolymorphismwithinthedat1geneandthemesolimbicpathwayinparkinsonsdisease
AT bardiensoraya associationbetweenavariablenumbertandemrepeatpolymorphismwithinthedat1geneandthemesolimbicpathwayinparkinsonsdisease
AT carrjonathan associationbetweenavariablenumbertandemrepeatpolymorphismwithinthedat1geneandthemesolimbicpathwayinparkinsonsdisease
AT abrahamsshameemah associationbetweenavariablenumbertandemrepeatpolymorphismwithinthedat1geneandthemesolimbicpathwayinparkinsonsdisease